Skip to main content
SpringerLink
Log in

Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Praziquantel (PZQ) is the recommended, effective, and safe treatment against all forms of schistosomiasis. Solid dispersions (SDs) in water-soluble polymers have been reported to increase solubility and bioavailability of poorly water-soluble drugs like PZQ, generally due to the amorphous form stabilization. In this work, poloxamer (PLX) 237 and poly(vinylpyrrolidone) (PVP) K30 were evaluated as potential carriers to revert PZQ crystallization. Binary and ternary SDs were prepared by the solvent evaporation method. PZQ solubility increased similarly with PLX either as binary physical mixtures or SDs. Such unpredicted data correlated well with crystalline PZQ and PLX as detected by solid-state NMR (ssNMR) and differential scanning calorimetry in those samples. Ternary PVP/PLX/PZQ SDs showed both ssNMR broad and narrow superimposed signals, thus revealing the presence of amorphous and crystalline PZQ, respectively, and exhibited the highest PZQ dissolution efficiency (up to 82% at 180 min). SDs with PVP provided a promising way to enhance solubility and dissolution rate of PZQ since PLX alone did not prevent recrystallization of amorphous PZQ. Based on ssNMR data, novel evidences on PLX structure and molecular dynamics were also obtained. As shown for the first time using ssNMR, propylene glycol and ethylene glycol constitute the PLX amorphous and crystalline components, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. WHO, 2017a. World Health Organization. Media Center. Schistosomiasis. http://www.who.int/mediacentre/factsheets/fs115/en/. Accessed 10 Aug 2017.

  2. WHO, 2017b. World Health Organization. Schistosomiasis. Strategy. http://www.who.int/schistosomiasis/strategy/en/. Accessed 10 Aug 2017.

  3. Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265–78. https://doi.org/10.1016/j.ejpb.2004.03.001.

    Article  PubMed  Google Scholar 

  4. De La Torre P, Torrado S, Torrado S. Preparation, dissolution and characterization of praziquantel solid dispersions. Chem Pharm Bull. 1999;47(11):1629–33. https://doi.org/10.1248/cpb.47.1629.

    Article  Google Scholar 

  5. Frezza TF, Gremião MP, Zanotti-Magalhães EA, Magalhães LA, Ribeiro de Souza AL, Allegretti SM. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay. Acta Trop. 2013;128(1):70–5. https://doi.org/10.1016/j.actatropica.2013.06.011.

    Article  CAS  PubMed  Google Scholar 

  6. Meyer T, Sekljic H, Fuchs S, Bothe H, Schollmeyer D, Miculka C. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl Trop Dis. 2009;3(1):e357. https://doi.org/10.1371/journal.pntd.0000357.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Perissutti B, Passerini N, Trastullo R, Keiser J, Zanolla D, Zingone G, et al. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: the case of praziquantel. Int J Pharm. 2017;533(2):402–12. https://doi.org/10.1016/j.ijpharm.2017.05.053.

    Article  CAS  Google Scholar 

  8. Arrúa EC, Ferreira MJG, Salomon CJ, Nunes TG. Elucidating the guest-host interactions and complex formation of praziquantel and cyclodextrin derivatives by 13C and 15N solid-state NMR spectroscopy. Int J Pharm. 2015;496(2):812–21. https://doi.org/10.1016/j.ijpharm.2015.11.026.

    Article  PubMed  Google Scholar 

  9. Chaud MV, Tamascia P, de Lima AC, Paganelli MO, Gremião MPD, de Freitas O. Solid dispersions with hydrogenated castor oil increase solubility, dissolution rate and intestinal absorption of praziquantel. Braz J Pharm Sci. 2010;46(3):473–81. https://doi.org/10.1590/S1984-82502010000300010.

    Article  CAS  Google Scholar 

  10. Bagade O, Shete A, Dhole S, Pujari R, Raskar V, Kharat P. Design and statistical optimisation of praziquantel tablets by using solid dispersion approach. Asian J Pharm. 2015;9(2):83–92. https://doi.org/10.4103/0973-8398.154689.

    Article  CAS  Google Scholar 

  11. Dametto PR, Dametto AC, Polese L, Ribeiro CA, Chorilli M, de Freitas O. Development and physicochemical characterization of solid dispersions containing praziquantel for the treatment of schistosomiasis. J Therm Anal Calorim. 2017;127(2):1693–706. https://doi.org/10.1007/s10973-016-5759-1.

    Article  CAS  Google Scholar 

  12. Baghel S, Cathcart H, O'Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527–44. https://doi.org/10.1016/j.xphs.2015.10.008.

    Article  CAS  PubMed  Google Scholar 

  13. Tian Y, Jones DS, Andrews GP. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Mol Pharm. 2015;12(4):1180–92. https://doi.org/10.1021/mp500702s.

    Article  CAS  PubMed  Google Scholar 

  14. Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res. 2004;21(10):1762–9. https://doi.org/10.1023/B:PHAM.0000045226.42859.b8.

    Article  CAS  PubMed  Google Scholar 

  15. Shah J, Vasanti S, Anroop B, Vyas H. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation. J Incl Phenom Macrocycl Chem. 2009;63(1-2):69–75. https://doi.org/10.1007/s10847-008-9490-9.

    Article  CAS  Google Scholar 

  16. Joe JH, Lee WM, Park YJ, Joe KH, DH O, Seo YG, et al. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm. 2010;395(1-2):161–6. https://doi.org/10.1016/j.ijpharm.2010.05.023.

    Article  CAS  PubMed  Google Scholar 

  17. Costa ED, Priotti J, Orlandi S, Leonardi D, Lamas MC, Nunes TG, et al. Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study. Int J Pharm. 2016;511(2):983–93. https://doi.org/10.1016/j.ijpharm.2016.08.009.

    Article  CAS  PubMed  Google Scholar 

  18. Devi DR, Sandhya P, Hari BV. Poloxamer: a novel functional molecule for drug delivery and gene therapy. J Pharm Sci Res. 2013;5:159–65.

    Google Scholar 

  19. Pitto-Barry A, Barry NPE. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem. 2014;5(10):3291–7. https://doi.org/10.1039/C4PY00039K.

    Article  CAS  Google Scholar 

  20. Beck-Broichsitter M, Bohr A, Ruge CA. Poloxamer-decorated polymer nanoparticles for lung surfactant compatibility. Mol Pharm. 2017;14(10):3464–72. https://doi.org/10.1021/acs.molpharmaceut.7b00477.

    Article  CAS  PubMed  Google Scholar 

  21. Essa EA, Balata GF. Preparation and characterization of domperidone solid dispersions. Pak J Pharm Sci. 2012;25(4):783–91.

    CAS  PubMed  Google Scholar 

  22. Rao M,M,Y, Khole I, Munjapara G. Characterization of solid dispersions of simvastatin with PVP K30 and Poloxamer 188. Ind J Pharm Edu Res. 2011;45:145–52.

    Google Scholar 

  23. Fousteris E, Tarantili PA, Karavas E, Bikiaris D. Poly(vinyl pyrrolidone)–poloxamer-188 solid dispersions prepared by hot melt extrusion. J Therm Anal Calorim. 2013;113(3):1037–47. https://doi.org/10.1007/s10973-012-2885-2.

    Article  CAS  Google Scholar 

  24. Chen Z, Liu Z, Qian F. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers. Mol Pharm. 2015;12(2):590–9. https://doi.org/10.1021/mp500661v.

    Article  CAS  PubMed  Google Scholar 

  25. United States Pharmacopeia and National Formulary (USP 30 NF 25). Rockville, MD: United States Pharmacopeial Convention; 2007.

  26. Moura Ramos JJ, Taveira-Marques R, Diogo HP. Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition. J Pharm Sci. 2004;93(6):1503–7. https://doi.org/10.1002/jps.20061.

    Article  Google Scholar 

  27. Dixon WT, Schaefer J, Sefcik MD, Stejskal EO, McKay RA. Total suppression of sidebands in CPMAS C-13 NMR. J Magn Reson. 1982;49(2):341–5. https://doi.org/10.1016/0022-2364(82)90199-8.

    CAS  Google Scholar 

  28. Kolodziejski W, Klinowski J. Kinetics of cross-polarization in solid-state NMR: a guide for chemists. Chem Rev. 2002;102(3):613–28. https://doi.org/10.1021/cr000060n.

    Article  CAS  PubMed  Google Scholar 

  29. Oo MK, Mandal UK, Chatterjee B. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. Pharm Dev Technol. 2015;22(1):2–12. https://doi.org/10.3109/10837450.2015.1116568.

    Google Scholar 

  30. Kolašinac N, Kachrimanis K, Homšek I, Grujić B, Ðurić Z, Ibrić S. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 2012;436(1-2):161–70. https://doi.org/10.1016/j.ijpharm.2012.06.060.

    Article  PubMed  Google Scholar 

  31. Chan S-Y, Chung Y-Y, Cheah X-Z, Tan EY-L, Quah J. The characterization and dissolution performances of spray dried solid dispersion of ketoprofen in hydrophilic carriers. Asian J Pharm Sci. 2015;10(5):372–85. https://doi.org/10.1016/j.ajps.2015.04.003.

    Article  Google Scholar 

  32. Hasegawa Y, Higashi K, Yamamoto K, Moribe K. Direct evaluation of molecular states of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopies. Mol Pharm. 2015;12(5):1564–72. https://doi.org/10.1021/mp500872g.

    Article  CAS  PubMed  Google Scholar 

  33. Hediger S, Emsley L, Fischer M. Solid-state NMR characterization of hydration effects on polymer mobility in onion cell-wall material. Carbohydr Res. 1999;322(1-2):102–12. https://doi.org/10.1016/S0008-6215(99)00195-0.

    Article  CAS  Google Scholar 

  34. Reinsberg SA, Ando S, Harris RK. Fluorine-19 NMR investigation of poly(trifluoroethylene). Polymer. 2000;41(10):3729–36. https://doi.org/10.1016/S0032-3861(99)00518-2.

    Article  CAS  Google Scholar 

  35. Koenig JL. Spectroscopy of polymers. 2nd ed. New York: Elsevier Science Inc; 1999.

    Google Scholar 

  36. Trastullo R, Dolci LS, Passerini N, Albertini B. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children. Int J Pharm. 2015;495(1):536–50. https://doi.org/10.1016/j.ijpharm.2015.09.019.

    Article  CAS  PubMed  Google Scholar 

  37. Blundell DJ. On the interpretation of multiple melting peaks in poly(ether ether ketone). Polymer. 1987;28(13):2248–51. https://doi.org/10.1016/0032-3861(87)90382-X.

    Article  CAS  Google Scholar 

  38. Alizadeh A, Richardson L, Xu J, McCartney S, Marand H, Cheung Y, et al. Influence of structural and topological constraints on the crystallization and melting behavior of polymers. 1. Ethylene/1-octene copolymers. Macromolecules. 1999;32(19):6221–35. https://doi.org/10.1021/ma990669u.

    Article  CAS  Google Scholar 

  39. Nasu M, Nemoto T, Mimura H, Sako K. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13C solid-state nuclear magnetic resonance using 1H T1rho relaxation time. J Pharm Sci. 2013;102(1):154–61. https://doi.org/10.1002/jps.23345.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

J.P thanks CONICET (Argentina) for a Ph.D. fellowship. The authors thank Msc. E. Costa for the acquisition of some DSC and NMR data during his fellowship period (FCT, BL-CQE/2015-011) and Dr. M.J. Ferreira for NMR assistance.

Funding

Thanks are due for financial support to Fundação para Ciência e Tecnologia (FCT, Portugal, projects RECI/QEQ-QIN/0189/2012 and UID/QUI/00100/2013) and UNR (Argentina), CONICET (Argentina), and MINCYT (Argentina) (PICT 1078).

Author information

Authors and Affiliations

  1. IQUIR-CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Área Técnica Farmacéutica, Universidad Nacional de Rosario, Suipacha 531, Rosario, Argentina

    Silvina Orlandi, Josefina Priotti, Dario Leonardi & Claudio J. Salomon

  2. CQE, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisbon, Portugal

    Hermínio P. Diogo & Teresa G. Nunes

Authors
  1. Silvina Orlandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josefina Priotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hermínio P. Diogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dario Leonardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudio J. Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Teresa G. Nunes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Claudio J. Salomon or Teresa G. Nunes.

Electronic Supplementary Material

ESM 1

(DOC 1435 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orlandi, S., Priotti, J., Diogo, H.P. et al. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution. AAPS PharmSciTech 19, 1274–1286 (2018). https://doi.org/10.1208/s12249-017-0946-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-017-0946-3

KEY WORDS

Search

Navigation